Pharem and Lonza Solutions initiate treatment project
Pharem and Lonza Solutions initiate treatment project

News -

Lonza Solutions orders Zymatic project from Pharem

Lonza Solutions and Pharem Biotech have started a new water treatment project together. Using Zymatic, Pharem's enzymatic treatment technology, the treatment step will be tailored to target and treat various organic compounds in one or more selected process streams.

Zymatic is a treatment technology which uses enzymatic catalysts for cost-effective treatment of challenging organic substances in various aquatic environments. This includes process water from the pharmaceutical and chemical industries. Zymatic enables tailor-made water treatment based on customers' wishes and needs. The INDUSTRY solutions are a completely flexible water treatment solution that creates a tailored version of the zymatic sand (enzymes immobilized on a sand-like material). These tailored solutions can be designed to improve the overall performance of the process or stream and are used to break down or transform unwanted organic compounds, increase biodegradability, reduce existing emission levels to increase production and much more.

- We are very happy that Lonza Solutions chooses to work with us. This confirms the interest in our cell-free enzyme treatment technology. Zymatic can be used for various reasons and together with the project team at Lonza Solutions we have identified some streams where our technology can be applied. We have just started the project and are now focusing on developing the process.”, Maria Humble, CTO of Pharem Biotech

Lonza Solutions AG is a multinational company providing product development services to the pharmaceutical and biological industries, including organic, fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis, detection systems and other services for the bioscience sector.

More information is available at https://www.zymatic.com/industry

Contact: Christian Ryen, COO at Pharem Biotech AB:
E-mail: christian@pharem.se
Phone: +46 (0) 70 256 84 14

Related links

Topics

Categories

Contacts

Related content

  • Pharem brands the PFS technology to Zymatic and presents a flexible water treatment technology to the market.

    Pharem launches the Zymatic brand after completing the Horizon EU 2020 project

    The Horizon 2020 project (called PFS), which represented Pharem's wastewater treatment technology, has been completed with all important objectives achieved. The project demonstrated the capacity of the enzyme treatment technology under operating conditions at wastewater treatment plants (WWTPs) as well as its ability to remove a wide range of pharmaceutical residues found in effluent wastewater.

  • Pharem selected as Semi-Finalist in the QBE AcceliCity Resilience Challange 2021

    Pharem selected as semi-finalist for AcceliCITY 2021

    Of the more than 500 companies from 44 countries that applied to be a part of the AcceliCITY program, Pharem was one of the 50 selected companies that stood out as an exceptional contender. The applicants represent 24 different verticals such as, Internet of Things, AI/Machine Learning, Mobility/Transportation, Urban Agriculture, Smart Health, Smart Water, Security, Environment, to name a few.

Enter your email address to follow Pharem Biotech AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Pharem Biotech AB.

Okay